Finance

Lists
AUPH:NASDAQ
Aurinia Pharmaceuticals Inc
US$ १५.७४
-०.५४%
(-०.०८५) 1D
अक्टोबर ५, १५:४५:३८ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUPH...
Open
US$ १५.७६
High
US$ १५.८०
Low
US$ १५.६०
Mkt. cap
२.०९ अरब
Avg. vol.
८.२२ लाख
Volume
४.८६ लाख
P/E ratio
६.८८
52-wk high
US$ १९.२५
52-wk low
US$ १०.९२
EPS
US$ २.२९
Beta
१.६०
Shares outstanding
१३.३१ करोड
No. of employees
१२८
Open
US$ १५.७६
High
US$ १५.८०
Low
US$ १५.६०
Mkt. cap
२.०९ अरब
Avg. vol.
८.२२ लाख
Volume
४.८६ लाख
P/E ratio
६.८८
52-wk high
US$ १९.२५
52-wk low
US$ १०.९२
EPS
US$ २.२९
Beta
१.६०
Shares outstanding
१३.३१ करोड
No. of employees
१२८
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
१ दिन पहिले
KZR stock exits Nasdaq after Aurinia merger closes
About Aurinia Pharmaceuticals Inc
CEO-
Employees१२८
Founded२०१२
Headquartersएडमन्टन, अल्बर्टा, क्यानाडा
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to AUPH in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AUPH in the last 3 months.
Highest
Current US$ १५.७४
US$ २१.०० (+३३.३८%)
Average
US$ १८.०० (+१४.३२%)
Lowest
US$ १६.०० (+१.६२%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Martin PhD
Bloom Burton
Buy
Upgraded
US$ २१.००
+३३.४%
08/20/2026
Stacy Ku
TD Cowen
Buy
Maintained
US$ १७.००
+८%
08/19/2026
Douglas Miehm
RBC Capital
Hold
Maintained
US$ १६.००
+१.६%
08/07/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
US$ १७.००
+८%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
७.३५ करोड
७.७१ करोड
७.७७ करोड
८.३२ करोड
Cost of goods sold
८५.०४ लाख
४.०५ करोड
१.४० करोड
१.८३ करोड
Cost of revenue
८५.०४ लाख
४.०५ करोड
१.४० करोड
१.८३ करोड
Research and development expenses
८१.०८ लाख
-२.०९ करोड
-
१३.१० लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.६२ करोड
२.९३ करोड
२.२० करोड
२.३५ करोड
Operating expense
३.५२ करोड
-६३.७४ लाख
२.२३ करोड
१.८६ करोड
Total operating expenses
४.३७ करोड
३.४२ करोड
३.६३ करोड
३.६९ करोड
Operating income
२.९७ करोड
४.२९ करोड
४.१४ करोड
४.६३ करोड
Other non operating income
-
-
-
-
EBT including unusual items
३.२० करोड
३.५७ करोड
४.३९ करोड
४.८८ करोड
EBT excluding unusual items
३.२० करोड
३.५७ करोड
४.३९ करोड
४.८८ करोड
Income tax expense
४.११ लाख
-१७.५१ करोड
९५.७० लाख
१.१४ करोड
Effective tax rate
१.२९%
-४९०.६२%
२१.७९%
२३.३१%
Other operating expenses
९.२९ लाख
-१.४८ करोड
२.७९ लाख
-६२.३४ लाख
Net income
३.१६ करोड
२१.०८ करोड
३.४४ करोड
३.७४ करोड
Net profit margin
४२.९५%
२७३.३५%
४४.२१%
४४.९६%
Earnings per share
०.२३
१.५३
०.२५
०.२८
Interest and investment income
३३.१६ लाख
३४.९८ लाख
३५.१५ लाख
३३.९३ लाख
Interest expense
-१०.९९ लाख
-१०.४७ लाख
-१०.१२ लाख
-९.४८ लाख
Net interest expenses
२२.१७ लाख
२४.५१ लाख
२५.०३ लाख
२४.४५ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
३.४६ करोड
४.७८ करोड
४.६२ करोड
५.१२ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू